Personalized peptide vaccination in patients with refractory non-small cell lung cancer

By                        

International Journal of Oncology, Vol. 40, Iss. 5, 2012-01 ,pp. : 1492-1500

Spandidos Publications

Access to resources Recommend Favorite

Telomerase peptide vaccination: a phase I/II study in patients with non-small cell lung cancer

By Brunsvig Paal   Aamdal Steinar   Gjertsen Marianne   Kvalheim Gunnar   Markowski-Grimsrud Carrie   Sve Ingunn   Dyrhaug Marianne   Trachsel Sissel   Møller Mona   Eriksen Jon   Gaudernack Gustav  

Cancer Immunology, Immunotherapy, Vol. 55, Iss. 12, 2006-12 ,pp. : 1553-1564

Springer Publishing Company

Access to resources Recommend Favorite

Vinorelbine is well tolerated and active in the treatment of elderly patients with advanced non-small cell lung cancer. A two-stage phase II study

By Gridelli C.   Perrone F.   Gallo C.   De Marinis F.   Ianniello G.   Cigolari S.   Cariello S.   Di Costanzo F.   D'Aprile M.   Rossi A.   Migliorino R.   Bartolucci R.   Bianco A.R.   Pergola M.   Monfardini S.  

European Journal of Cancer, Vol. 33, Iss. 3, 1997-03 ,pp. : 392-397

Elsevier

Access to resources Recommend Favorite

A phase I multicenter study of antroquinonol in patients with metastatic non-small-cell lung cancer who have received at least two prior systemic treatment regimens, including one platinum-based chemotherapy regimen

By        

Molecular and Clinical Oncology, Vol. 3, Iss. 6, 2015-01 ,pp. : 1375-1380

Science Publishers

Access to resources Recommend Favorite

Feasibility of cisplatin/pemetrexed with 15 mg/kg bevacizumab for the treatment of patients with advanced non-squamous non-small cell lung cancer

By                      

Oncology Letters, Vol. 9, Iss. 6, 2015-01 ,pp. : 2577-2582

Spandidos Publications

Access to resources Recommend Favorite